Rare disease drugs

These companies develop and sell drugs for rare conditions, mostly inherited ones, as their main business.
+2.3%
over 6 months · S&P 500 +2.6%

Key indicators

Health
50 / 100
Fragile
Solid
Price
P/E 23
Cheap
Expensive
Up over 1 year
33 of 63
Wallets over 90 days
1 / 2 buys / sells
Buys
Sells
Health and price: against the other tags.

The 65 companies

VRTX
+23.3%
UTHR
+4.0%
ALNY
−42.5%
Others
Size: weight in the tag. Color: move over the period.
See all companies
V
Vertex Pharmaceuticals
VRTX
37.7%
+23.3%
I
Insmed
INSM
7.3%
+11.0%
U
United Therapeutics
UTHR
7.0%
+4.0%
A
Alnylam Pharmaceuticals
ALNY
6.1%
−42.5%
N
Neurocrine Biosciences
NBIX
4.8%
+5.7%
B
BridgeBio Pharma
BBIO
4.3%
+18.4%
B
BioMarin Pharmaceutical
BMRN
3.1%
+10.5%
K
Krystal Biotech
KRYS
2.5%
−0.3%
R
Rhythm Pharmaceuticals
RYTM
2.2%
+27.1%
M
Mirum Pharmaceuticals
MIRM
1.7%
−8.0%
S
Scholar Rock Holding
SRRK
1.5%
−12.5%
P
PTC Therapeutics
PTCT
1.5%
−11.2%
C
Cogent Biosciences
COGT
1.4%
−12.6%
L
Liquidia
LQDA
1.4%
+0.8%
I
Ionis Pharmaceuticals
IONS
1.3%
−60.9%
T
Travere Therapeutics
TVTX
1.3%
+18.9%
A
Amylyx Pharmaceuticals
AMLX
1.1%
+128.0%
I
Disc Medicine
IRON
1.1%
+19.7%
D
Dyne Therapeutics
DYN
0.9%
−0.8%
A
ACADIA Pharmaceuticals
ACAD
0.9%
−12.4%
D
Denali Therapeutics
DNLI
0.9%
+0.6%
P
Palvella Therapeutics
PVLA
0.7%
+33.5%
B
Beam Therapeutics
BEAM
0.7%
−18.3%
M
Maze Therapeutics
MAZE
0.6%
+34.3%
S
Sarepta Therapeutics
SRPT
0.5%
−8.4%
X
Xeris Biopharma
XERS
0.5%
+167.0%
B
BioCryst Pharmaceuticals
BCRX
0.5%
−15.6%
A
Agios Pharmaceuticals
AGIO
0.5%
+12.1%
E
Eton Pharmaceuticals
ETON
0.5%
+111.3%
C
Hemab Therapeutics
COAG
0.5%
+45.6%
S
Stoke Therapeutics
STOK
0.5%
−11.3%
P
Precigen
PGEN
0.5%
+2.7%
R
Ultragenyx Pharmaceutical
RARE
0.5%
−35.7%
T
Taysha Gene Therapies
TSHA
0.4%
−31.2%
A
Avalyn Pharma
AVLN
0.4%
+1.5%
S
Savara
SVRA
0.3%
−7.8%
M
MeiraGTx Holdings
MGTX
0.3%
−2.3%
I
Immix Biopharma
IMMX
0.2%
−21.1%
Z
Zevra Therapeutics
ZVRA
0.2%
−17.5%
S
Solid Biosciences
SLDB
0.2%
−1.2%
D
Design Therapeutics
DSGN
0.2%
−27.1%
C
Capricor Therapeutics
CAPR
0.2%
−66.9%
N
Neurogene
NGNE
0.1%
−19.8%
M
Monopar Therapeutics
MNPR
0.1%
+21.5%
T
Tectonic Therapeutic
TECX
0.1%
−24.2%
R
Rezolute
RZLT
0.1%
+9.4%
O
Ocugen
OCGN
<0.1%
−40.4%
F
Fulcrum Therapeutics
FULC
<0.1%
−43.6%
L
Larimar Therapeutics
LRMR
<0.1%
−15.6%
R
Rocket Pharmaceuticals
RCKT
<0.1%
−29.2%
L
Lexeo Therapeutics
LXEO
<0.1%
−43.6%
A
Arcturus Therapeutics
ARCT
<0.1%
+11.9%
T
Entrada Therapeutics
TRDA
<0.1%
−20.2%
K
Korro Bio
KRRO
<0.1%
+33.7%
P
PepGen
PEPG
<0.1%
+181.3%
S
Sionna Therapeutics
SION
<0.1%
−91.7%
I
Inovio Pharmaceuticals
INO
<0.1%
+10.0%
A
Abeona Therapeutics
ABEO
<0.1%
−55.9%
S
Spruce Biosciences
SPRB
<0.1%
−19.5%
A
Aardvark Therapeutics
AARD
<0.1%
−70.9%
A
Ascendis Pharma
ASND
+14.5%
J
Jazz Pharmaceuticals
JAZZ
+5.6%
P
Pharvaris
PHVS
+9.7%
Q
uniQure
QURE
−12.0%
S
Sol-Gel Technologies
SLGL
−24.2%